Investigating e-cigarette use trends among U.S. adolescents and young adults.
E-Cigarette Use among U.S. Adolescents and Young Adults: Longitudinal Associations with Tobacco Use and Health and Dimensions of Risk and Protection
This study looks at how young people in the U.S. use e-cigarettes over time and how it relates to smoking and other substances, helping us learn more about the health effects and what influences their choices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10984467 on NIH RePORTER |
What this research studies
This research examines how e-cigarette use among adolescents and young adults in the U.S. evolves over time and its connections to cigarette smoking and other substance use. By analyzing data over several years, the study aims to understand the long-term effects of e-cigarettes on health and the factors that influence their use, including age, sex, race, and educational background. The research employs advanced statistical methods to address biases in self-reported data and to track changes in usage patterns. Participants will contribute to a better understanding of nicotine dependence and cessation efforts.
Who could benefit from this research
Good fit: Ideal candidates for this research include U.S. adolescents and young adults aged 12 to 21 who use e-cigarettes or other tobacco products.
Not a fit: Patients who are older than 21 or do not use e-cigarettes or tobacco products may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and intervention strategies for nicotine and tobacco use among young people.
How similar studies have performed: Previous research has shown that longitudinal studies can effectively track substance use trends, suggesting that this approach may yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Evans-Polce, Rebecca J. — University of Michigan at Ann Arbor
- Study coordinator: Evans-Polce, Rebecca J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.